Skip to main content

Regulation

By Dave Muoio | 01:28 pm | October 21, 2020
Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries.
By Laura Lovett | 01:10 pm | October 21, 2020
AppliedVR's EaseVRx landed an FDA Breakthrough Device designation for its tool that combines VR and cognitive behavioral therapy. 
By Dave Muoio | 04:09 pm | October 12, 2020
More expertise will be necessary if the regulator is to keep up with the constant evolution of real-world evidence, privacy and other data-driven challenges, Dr. Hahn said.
By MobiHealthNews | 12:42 pm | October 09, 2020
Bradley Merrill Thompson, an FDA-watcher, lawyer and occasional MobiHealthNews guest contributor, joins the MobiHealthNews team for a closer look at what the FDA has been up to around digital health and AI.
By Dave Muoio | 04:05 pm | October 06, 2020
Dascena's COViage system uses demographic and vital-sign data pulled from a COVID-19 patients' EHR to calculate their risk of hemodynamic instability or respiratory failure.
By Dave Muoio | 05:00 pm | September 22, 2020
Although still a work in progress, the new center will reportedly help coordinate digital health projects within the agency while providing expertise to external stakeholders.
By Laura Lovett | 04:16 pm | September 17, 2020
Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold. 
By Laura Lovett | 03:49 pm | September 15, 2020
The new tool can monitor a patient's end-tidal carbon dioxide, respiratory rate, and fractional inspired CO2.
By Mallory Hackett | 12:44 pm | September 14, 2020
The ECG app can detect over 98% of atrial fibrillation cases and was 100% accurate in identifying participants with normal sinus rhythm, according to study results.
By Tammy Lovell | 02:27 pm | September 07, 2020
The UK government has released a proposed regime on the regulation of medical devices in Great Britain, Northern Ireland and the European Union post Brexit.